{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Chlorogenic acid", "Crescentia cujete", "Isoflavone", "Luteolin", "Molecular dynamics simulation", "Type-2 diabetes mellitus", "Xylocaine"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37969920", "DateRevised": {"Year": "2024", "Month": "02", "Day": "12"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "07", "Day": "01"}], "Language": ["eng"], "ELocationID": ["10.1007/s40200-023-01249-7"], "Journal": {"ISSN": "2251-6581", "JournalIssue": {"Volume": "22", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Dec"}}, "Title": "Journal of diabetes and metabolic disorders", "ISOAbbreviation": "J Diabetes Metab Disord"}, "ArticleTitle": "Cheminformatics identification of modulators of key carbohydrate-metabolizing enzymes from <i>C. cujete</i> for type-2 diabetes mellitus intervention.", "Pagination": {"StartPage": "1299", "EndPage": "1317", "MedlinePgn": "1299-1317"}, "Abstract": {"AbstractText": ["The therapeutic use of oral hypoglycaemic agents in the management of type-2 diabetes mellitus (T2DM) is without adverse effects; thus, calls for alternative and novel candidates from natural products in medicinal plants.", "The study explored molecular docking and molecular dynamics (MD) simulation approaches to identify key antidiabetic metabolites from <i>Crescentia cujete</i>.", "Molecular docking results identified four and/or five best compounds against each target enzyme (alpha-glucosidase, dipeptidyl peptidase-IV, aldose reductase, and protein tyrosine phosphatase-1B (PTP-1B)) implicated in diabetes. The resulting complexes (except against PTP-1B) had higher docking scores above respective standards (acarbose, Diprotin A, ranirestat). The MD simulation results revealed compounds such as benzoic acid (-48.414\u00a0kcal/mol) and phytol (-45.112\u00a0kcal/mol) as well as chlorogenic acid (-42.978\u00a0kcal/mol) and naringenin (-31.292\u00a0kcal/mol) had higher binding affinities than the standards [acarbose (-28.248\u00a0kcal/mol), ranirestat (-21.042\u00a0kcal/mol)] against alpha-glucosidase and aldose reductase, respectively while Diprotin A (-45.112\u00a0kcal/mol) and ursolic acid (-18.740\u00a0kcal/mol) presented superior binding affinities than the compounds [luteolin (-41.957\u00a0kcal/mol and naringenin (-16.518\u00a0kcal/mol)] against DPP-IV and PTP-1B respectively.", "While isoflavone (alpha-glucosidase), xylocaine (DPP-IV), luteolin (aldose reductase,) and chlorogenic acid (PTP-1B) were affirmed as the best inhibitors of respective enzyme targets, luteolin, and chlorogenic acid may be suggested and proposed as probable candidates against T2DM and related retinopathy complication based on their structural stability, compactness and affinity for three (DPP-IV, aldose reductase, and PTP-1B) of the four targets investigated. Further studies are warranted in vitro and in vivo on the antihyperglycaemic effects of these drug candidates.", "The online version contains supplementary material available at 10.1007/s40200-023-01249-7."], "CopyrightInformation": "\u00a9 The Author(s) 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/0303y7a51", "grid.412114.3", "0000 0000 9360 9165"], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, P.O. Box 1334, Durban, 4000 South Africa."}], "LastName": "Balogun", "ForeName": "Fatai Oladunni", "Initials": "FO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/0303y7a51", "grid.412114.3", "0000 0000 9360 9165"], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, P.O. Box 1334, Durban, 4000 South Africa."}, {"Identifier": ["https://ror.org/054r97095", "grid.429399.c", "0000 0004 0630 4697"], "Affiliation": "Department of Nature Conservation, Mangosuthu University of Technology, Mangosuthu, South Africa."}], "LastName": "Singh", "ForeName": "Karishma", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/0303y7a51", "grid.412114.3", "0000 0000 9360 9165"], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, P.O. Box 1334, Durban, 4000 South Africa."}], "LastName": "Rampadarath", "ForeName": "Athika", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/0303y7a51", "grid.412114.3", "0000 0000 9360 9165"], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, P.O. Box 1334, Durban, 4000 South Africa."}], "LastName": "Akoonjee", "ForeName": "Ayesha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/0303y7a51", "grid.412114.3", "0000 0000 9360 9165"], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, P.O. Box 1334, Durban, 4000 South Africa."}], "LastName": "Naidoo", "ForeName": "Kayleen", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["https://ror.org/0303y7a51", "grid.412114.3", "0000 0000 9360 9165"], "Affiliation": "Department of Biotechnology and Food Science, Faculty of Applied Sciences, Durban University of Technology, P.O. Box 1334, Durban, 4000 South Africa."}], "LastName": "Sabiu", "ForeName": "Saheed", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "J Diabetes Metab Disord", "NlmUniqueID": "101590741", "ISSNLinking": "2251-6581"}, "CoiStatement": "Competing interestsNo conflicting interest among the authors."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Sapra A, Bhandari P, Diabetes Mellitus. [Updated 2021 Sep 18]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK551501/. Accessed 20 Jan 2022."}, {"Citation": "WHO, Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed Dec 13 2021."}, {"Citation": "Westman EC. Type 2 diabetes Mellitus: a pathophysiologic perspective. Front Nutr. 2021;8.https://doi=10.3389/fnut.2021.707371.", "ArticleIdList": ["PMC8384107", "34447776"]}, {"Citation": "American Diabetes Association. Diagnosis and classification of diabetes mellitus. 2011."}, {"Citation": "Cho NH, Shaw JE, Karuranga S. IDF diabetes atlas: global estimates of diabetes prevalence of for 2017 and projections for 2045. J Diab. 2018;138:271\u201328.", "ArticleIdList": ["29496507"]}, {"Citation": "Ali MY, Jannat S, Rahman MM. Investigation of C-glycosylated apigenin and luteolin derivatives\u2019 effects on protein tyrosine phosphatase 1B inhibition with molecular and cellular approaches. Comput Toxicol. 2020 doi: 10.1016/j.comtox.2020.100141.", "ArticleIdList": ["10.1016/j.comtox.2020.100141"]}, {"Citation": "Dodds S. The how-to-for type 2: an overview of diagnosis and management of type 2 diabetes mellitus. Nurs Clin North Am. 2017;52:513\u201322. doi: 10.1016/j.cnur.2017.07.002.", "ArticleIdList": ["10.1016/j.cnur.2017.07.002", "29080574"]}, {"Citation": "Kazmi M, Zaib S, Ibrar A, Amjad ST, Shafique Z, Mehsud S, et al. A new entry into the portfolio of \u03b1-glucosidase inhibitors as potent therapeutics for type 2 diabetes: design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. Bioorg Chem. 2018;77:190\u2013202. doi: 10.1016/j.bioorg.2017.12.022.", "ArticleIdList": ["10.1016/j.bioorg.2017.12.022", "29421697"]}, {"Citation": "Liu S-K, Hao H, Bian Y, Ge Y-X, Lu S, Xie H-X, Wang K-M, Tao H, Yuan C, Zhang J, Zhang J, Jiang C-S, Zhu K. Discovery of new \u03b1-glucosidase inhibitors: structure-based virtual screening and biological evaluation. Front Chem. 2021;9:639279. https://doi.10.3389/fchem.2021.639279.", "ArticleIdList": ["PMC7982526", "33763406"]}, {"Citation": "Rosa MM, Dias T. Commonly used endocrine drugs. Edited by Jos\u00e9 Biller, Jos\u00e9 M. Ferro. Handbook of clinical neurology. Elsevier Publishers; 2014;120:809\u201324.", "ArticleIdList": ["24365354"]}, {"Citation": "Huang PK, Lin SR, Chang CH, et al. Natural phenolic compounds potentiate hypoglycemia via inhibition of dipeptidyl peptidase IV. Sci Rep. 2019;9:15585. doi: 10.1038/s41598-019-52088-7.", "ArticleIdList": ["10.1038/s41598-019-52088-7", "PMC6821704", "31666589"]}, {"Citation": "Zhao BT, Le DD, Nguyen PH, Ali My, Choi JS, Min BS, Shin HN, Rhee HI, Woo MH. PTP1B, alpha-glucosidase and DPPIV inhibitory effects of chromene derivatives from the leaves of Smilax china L. Chem Biol Interact. 2016;25(253):27\u201337. doi: 10.1016/j.cbi.2016.04.012.", "ArticleIdList": ["10.1016/j.cbi.2016.04.012", "27060210"]}, {"Citation": "Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366(13):1227\u201339. doi: 10.1056/NEJMra1005073.", "ArticleIdList": ["10.1056/NEJMra1005073", "22455417"]}, {"Citation": "Duh EJ, Sun JK, Stitt AW. Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI Insight. 2017;2(14):e93751. doi: 10.1172/jci.insight.93751.", "ArticleIdList": ["10.1172/jci.insight.93751", "PMC5518557", "28724805"]}, {"Citation": "Mohammed Q, Gilles MC, Wong TY. Management of diabetes retinopathy: a systematic review. J Am Med Assoc. 2017;208:902\u201316."}, {"Citation": "Karasu C, Cumao\u02d8 glu A, G\u00fcrpinar AR, Kartal M, Kovacikova L, Milackova I, Stefek M. Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extracts. Interdiscip Toxicol. 2012;5:15\u201320. doi: 10.2478/v10102-012-0003-8.", "ArticleIdList": ["10.2478/v10102-012-0003-8", "PMC3389504", "22783144"]}, {"Citation": "Sabiu S, O\u2019Neill FH, Ashafa AOT. Kinetics of \u03b1-amylase and \u03b1-glucosidase inhibitory potential of Zea mays Linnaeus (Poaceae), Stigma maydis aqueous extract: an in vitro assessment. J Ethnopharmacol. 2016;183. 10.1016/j.jep.2016.02.024.", "ArticleIdList": ["26902829"]}, {"Citation": "Balogun FO, Ashafa AOT. Aqueous root extract of Dicoma anomala (Sond.) Extenuates postprandial hyperglycaemia in vitro and its modulation on the activities of carbohydrate-metabolism enzymes in streptozotocin \u2013induced diabetic Wistar rats. S Afr J Bot. 2017;112:102\u201312. doi: 10.1016/j.sajb.2017.05.014.", "ArticleIdList": ["10.1016/j.sajb.2017.05.014"]}, {"Citation": "Sabiu S, Balogun FO, Amoo SO. Phenolics profiling of Carpobrotus edulis (L.) NE Br. And insights into molecular dynamics of their significance in type 2 diabetes therapy and its retinopathy complication. Mol. 2021;26:4867. doi: 10.3390/molecules26164867.", "ArticleIdList": ["10.3390/molecules26164867", "PMC8401050", "34443458"]}, {"Citation": "Ebrahimie M, Bahmani M, Shirzad H, Rafieian-Kopaei M, Saki K. A review study on the effect of iranian herbal medicines on opioid withdrawal syndrome. J Evid Based Complementary Altern Med. 2015;20:302\u20139. doi: 10.1177/2156587215577896.", "ArticleIdList": ["10.1177/2156587215577896", "25818661"]}, {"Citation": "Bahmani M, Rafieian-Kopaei M, Naghdi N, Nejad ASM, Afsordeh O. Physalis alkekengi: a review of its therapeutic effects. J Chem Pharm Sci. 2016;9(3):1472\u201385."}, {"Citation": "Mozaffari Nejad AS, Kamkar A, Giri A, Pourmahmoudi AA. Ethnobotany and folk medicinal uses of major trees and shrubs in Northern Iran. J Med Plants Res. 2013;7:284\u20139."}, {"Citation": "Bahmani M, Shirzad H, Rafieian S, Rafieian Kopaei M. Silybum marianum: beyond Hepatoprotection. Evid J Based Complementary Altern Med. 2015;20:292\u2013301. doi: 10.1177/2156587215571116.", "ArticleIdList": ["10.1177/2156587215571116", "25686616"]}, {"Citation": "Balogun FO, Sabiu S, Bignoniaceae A review of the phytochemistry, ethnobotany, toxicology, and pharmacological potentials of Crescentia cujete L. Evidence-Based Complement Altern Med. 2021;6683708:15pages. doi: 10.1155/2021/6683708.", "ArticleIdList": ["10.1155/2021/6683708", "PMC8282368", "34306151"]}, {"Citation": "Parente FGG, de Oliveira AP, Rodrigues CMSC. Phytochemical screening and antioxidant activity of methanolic fraction from the leaves of Crescentia cujete L. (Bignoniaceae) J Chem Pharm Res. 2017;8(2):231\u20136."}, {"Citation": "Iwueke AV, Nwodo OFC. Antihyperglycaemic effect of aqueous extract of Daniella oliveri and Sarcocephalus latifolius roots on key carbohydrate metabolic enzymes and glycogen in experimental diabetes. Biokemistri. 2008;20 (2)."}, {"Citation": "Atolani O, Olatunji GA. Isolation and evaluation of antiglycation potential of polyalthic acid (furano-terpene) from Daniella oliveri. J Pharm Anal. 2014;4(6):407\u201311. doi: 10.1016/j.jpha.2014.05.002.", "ArticleIdList": ["10.1016/j.jpha.2014.05.002", "PMC5761355", "29403907"]}, {"Citation": "Shauibu G, Abu AH, Agwu EO, Ehile V, Ezeudo ZE, Ogedemgbe B, Peter S. Effects of Daniella oliveri aqueous leaves extract on blood glucose, haematological and biochemical values in streptozotocin-induced type 2 diabetes in male albino rats. Vom J Vet Sci. 2018;13(1):81\u20137."}, {"Citation": "Adeyemi SB, Surana V, Krishnamurthy R. In-vitro inhibition of type 2 diabetes key enzymes; effect of extracts and solvent-solvent fractions of Daniellia oliveri (Rolfe) Hutch. & Dalziel. Bull Pharm Sci Assiut Uni. 2021;44(2):415\u201326. doi: 10.21608/bfsa.2021.207160.", "ArticleIdList": ["10.21608/bfsa.2021.207160"]}, {"Citation": "Sempor\u00e9 JN, Diao M, Ouattara L, Ouoba P, Kagambega W, Sama H, Dibala CI, Konat\u00e9 K, Dicko MH. Potential antidiabetic effects of extracts from four medicinal plants used in Burkina Faso by inhibition of alpha-amylase. Diab. 2021;2(4):250\u20138."}, {"Citation": "Branden G, Sjogren T, Schnecke V, Xue Y. Structure-based ligand design to overcome CYP inhibition in drug discovery projects. Drug Discov Today. 2014;19:905\u201311. doi: 10.1016/j.drudis.2014.03.012.", "ArticleIdList": ["10.1016/j.drudis.2014.03.012", "24642031"]}, {"Citation": "Ambrose GO, Afees OJ, Nwamaka NC, Simon N, Oluwaseun AA, Soyinka T, Bankole S. Selection of Luteolin as a potential antagonist from molecular docking analysis of EGFR mutant. Bioinform. 2018;14:241. doi: 10.6026/97320630014241.", "ArticleIdList": ["10.6026/97320630014241", "PMC6077815", "30108422"]}, {"Citation": "Ali DM, Saalis JM, Sathya R, Irfan N, Kim JW. An evidence of microalgal peptides to target spike protein of COVID-19: in silico approach. Microb Pathog. 2021;160:105189. doi: 10.1016/j.micpath.2021.105189.", "ArticleIdList": ["10.1016/j.micpath.2021.105189", "PMC8436434", "34530072"]}, {"Citation": "Ortiz CLD, Completo GC, Nacario RC, et al. Potential inhibitors of galactofuranosyltransferase 2 (GlfT2): molecular docking, 3D-QSAR, and in silico ADMETox studies. Sci Rep. 2019;9:17096. doi: 10.1038/s41598-019-52764-8.", "ArticleIdList": ["10.1038/s41598-019-52764-8", "PMC6863818", "31745103"]}, {"Citation": "Seifert E. 2014. Origin Pro 9.1: Scientific Data Analysis and Graphing Software-Software Review.", "ArticleIdList": ["10.1021/ci500161d", "24702057"]}, {"Citation": "Sliwoski G, Kothiwale S, Meiler J, Lowe EW., Jr Computational methods in drug discovery. Pharmacol Rev. 2014;66(1):334\u201395. doi: 10.1124/pr.112.007336.", "ArticleIdList": ["10.1124/pr.112.007336", "PMC3880464", "24381236"]}, {"Citation": "Salmaso V, Moro S. Bridging molecular docking to molecular dynamics in exploring ligand-protein recognition process: An overview. Front Pharmacol. 2018;9. https://.doi.10.3389/fphar.2018.00923.", "ArticleIdList": ["PMC6113859", "30186166"]}, {"Citation": "Akinyede KA, Oyewusi HA, Hughes GD, Ekpo OE, Oguntibeju OO. In vitro evaluation of the anti-diabetic potential of aqueous acetone Helichrysum petiolare extract (AAHPE) with molecular docking relevance in diabetes mellitus. Mol. 2021;27(1):155. https://.doi.10.3390/molecules27010155.", "ArticleIdList": ["PMC8746515", "35011387"]}, {"Citation": "Rampadarath A, Balogun FO, Charlene P, Sabiu S. Identification of flavonoid c-glycosides as promising antidiabetics targeting protein tyrosine phosphatase 1B. J Diab Res. 2022;6233217. 10.1155/2022/6233217.", "ArticleIdList": ["PMC9249544", "35782627"]}, {"Citation": "Dong Q, Hu N, Yue H, Wang H. Inhibitory activity and mechanism investigation of Hypericin as a novel \u03b1-Glucosidase inhibitor. Mol. 2021;26(15):4566. doi: 10.3390/molecules26154566.", "ArticleIdList": ["10.3390/molecules26154566", "PMC8348433", "34361714"]}, {"Citation": "Pan J, Zhang C, Yang W, Liu H, Lv Z, Liu J, Jiao Z. Inhibition of dipeptidyl peptidase-4 by flavonoids: structure-activity relationship, kinetics and interactions mechanism. Front Nutr. 2022;9:892426. doi: 10.3389/fnut.2022.892426.", "ArticleIdList": ["10.3389/fnut.2022.892426", "PMC9134086", "35634373"]}, {"Citation": "Decherchi S, Cavalli A. Thermodynamics and kinetics of drug-target binding by molecular simulation. Chem Rev. 2020;120(23):12788\u2013833. doi: 10.1021/acs.chemrev.0c00534.", "ArticleIdList": ["10.1021/acs.chemrev.0c00534", "PMC8011912", "33006893"]}, {"Citation": "Zabidi NA, Ishak NA, Hamid M, Ashari SE, Mohammad Latif MA. Inhibitory evaluation of Curculigo latifolia on glucosidase, DPP (IV) and in vitro studies in antidiabetic with molecular docking relevance to type 2 diabetes mellitus. J Enzym Inhib Med Chem. 2021;36:109\u201321. doi: 10.1080/14756366.2020.1844680.", "ArticleIdList": ["10.1080/14756366.2020.1844680", "PMC7717572", "33249946"]}, {"Citation": "Sindhu R, Binod P, Pandey A. Biological pretreatment of lignocellulosic biomass\u2014An overview. Bioresour Technol. 2015;199:76\u201382. doi: 10.1016/j.biortech.2015.08.030.", "ArticleIdList": ["10.1016/j.biortech.2015.08.030", "26320388"]}, {"Citation": "Salim B, Said G, Kambouche N, Kress S. Identification of phenolic compounds from Nettle as new candidate inhibitors of main enzymes responsible on type-II diabetes. Curr Drug Discov Technol. 2020;17:197. doi: 10.2174/1570163815666180829094831.", "ArticleIdList": ["10.2174/1570163815666180829094831", "30156162"]}, {"Citation": "Adinortey CA, Kwarko GB, Koranteng R, Boison D, Obuaba I, Wilson MD, Kwofie SK. Molecular structure-based screening of the constituents of Calotropis procera identifies potential inhibitors of diabetes mellitus target alpha glucosidase. Curr Issues Mol Biol. 2022;44:963\u201387. doi: 10.3390/cimb44020064.", "ArticleIdList": ["10.3390/cimb44020064", "PMC8928985", "35723349"]}, {"Citation": "Bower AM, Real Hernandez LM, Berhow MA, de Mejia EG. Bioactive compounds from culinary herbs inhibit a molecular target for type 2 diabetes management, dipeptidyl peptidase IV. J Agric Food Chem. 2014;62(26):6147\u201358. doi: 10.1021/jf500639f.", "ArticleIdList": ["10.1021/jf500639f", "24881464"]}, {"Citation": "Muralidharan N, Sakthivel R, Velmurugan D, Michael Gromiha M. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19. J Biomolec Struc Dyn. 2020. https://.doi.10.1080/07391102.2020.1752802.", "ArticleIdList": ["32248766"]}, {"Citation": "Childers MC, Daggett V. Insights from molecular dynamics simulations for computational protein design. Mol Syst Des Eng. 2017;12(1):9\u201333. doi: 10.1039/C6ME00083E.", "ArticleIdList": ["10.1039/C6ME00083E", "PMC5321087", "28239489"]}, {"Citation": "Eawsakul K, Ongtanasup T, Ngamdokmai N, et al. Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. Stems: an investigation by in silico and in vitro studies. BMC Complement Med Ther. 2023;23:25. doi: 10.1186/s12906-023-03857-5.", "ArticleIdList": ["10.1186/s12906-023-03857-5", "PMC9885589", "36717857"]}, {"Citation": "Rosenberg MS. Sequence alignment: methods, models, concepts and strategies. Bioinform 1972 httpsdoi:10.1525/9780520943742."}, {"Citation": "Fusani L, Palmer DS, Somers DO, Wall ID. Exploring ligand stability in protein crystal structures using binding pose metadynamics. J Chem Inf Model. 2020;60(3):1528\u201339. doi: 10.1021/acs.jcim.9b00843.", "ArticleIdList": ["10.1021/acs.jcim.9b00843", "PMC7145342", "31910338"]}, {"Citation": "Nath V, Manish R, Neeraj K et al. Computational identification of potential dipeptidyl peptidase (DPP)-IV inhibitors: Structure based virtual screening, molecular dynamics simulation and knowledge-based SAR studies. J Mole Struct. 2021;129006(2021). 10.1016/j.molstruc.2020.129006."}, {"Citation": "Arif R, Ahmad S, Mustafa G, Mahrosh HS, Ali M, Qamar MT, Dar HR. Molecular docking and simulation studies of antidiabetic agents devised from hypoglycemic polypeptide-P of Momordica charantia. BioMed Res Int. 2021;5561129. 10.1155/2021/5561129.", "ArticleIdList": ["PMC8476269", "34589547"]}, {"Citation": "Martinez L. Automatic identification of mobile and rigid Substructures in Molecular Dynamics Simulations and fractional structural fluctuation analysis. PLoS ONE 2015;10(3).", "ArticleIdList": ["PMC4376797", "25816325"]}, {"Citation": "Antony P, Vijayan R. Identification of novel aldose reductase inhibitors from spices: a molecular docking and simulation study. PLoS ONE. 2018;10(9):e0138186. doi: 10.1371/journal.pone.0138186.", "ArticleIdList": ["10.1371/journal.pone.0138186", "PMC4575143", "26384019"]}, {"Citation": "Khan MS, Qais FA, Rehman M, Ismail MH, Alokail MS, Altwaijry N, Alafaleq NO, AlAjmi MF, Salem N, Alqhatani R. Mechanistic inhibition of non-enzymatic glycation and aldose reductase activity by naringenin: binding, enzyme kinetics and molecular docking analysis. Int J Biol Macromol. 2020;159:87\u201397. doi: 10.1016/j.ijbiomac.2020.04.226.", "ArticleIdList": ["10.1016/j.ijbiomac.2020.04.226", "32437808"]}, {"Citation": "Shode FO, Idowu ASK, Uhomoibhi OJ, Sabiu S. Repurposing drugs and identification of inhibitors of integral proteins (spike protein and main protease) of SARS-CoV-2. J Biomol Struct Dyn. 2021.", "ArticleIdList": ["PMC7898306", "33590806"]}, {"Citation": "Galzitskaya OV, Garbuzynskiy SO. Entropy capacity determines protein folding. Proteins Struct Funct Genet. 2006;63:144\u201354. doi: 10.1002/prot.20851.", "ArticleIdList": ["10.1002/prot.20851", "16400647"]}, {"Citation": "Cherrak SA, Merzouk H, Mokhtari-Soulimane N. Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: a molecular docking and simulation studies. PLoS ONE. 2020;15(10):e0240653. doi: 10.1371/journal.pone.0240653.", "ArticleIdList": ["10.1371/journal.pone.0240653", "PMC7561147", "33057452"]}, {"Citation": "Chen J, Wu S, Zhang Q, Yin Z, Zhang L. \u03b1-Glucosidase inhibitory effect of anthocyanins from Cinnamomum camphora fruit: inhibition kinetics and mechanistic insights through in vitro and in silico studies. Int J Biol Macromol. 2020;143:696\u2013703. doi: 10.1016/j.ijbiomac.2019.09.091.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.09.091", "31521662"]}, {"Citation": "Cholko T, Chen W, Tang Z, Chang C. A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibilty and implication in drug discovery. J Comput Aided Mol Des. 2017;176:139\u201348.", "ArticleIdList": ["PMC6440799", "29737445"]}, {"Citation": "Jin Z, Du X, Xu Y, Deng Y, Liu M, Zhao Y, Zhang B, Li X, Zhang L, Peng C, Duan Y, Yu J, Wang L, Yang K, Liu F, Jiang R, Yang X, You T, Liu X, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582(7811):289\u201393. doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Aribisala JO, Abdulsalam RA, Dweba Y, Madonsela K, Sabiu S. Identification of secondary metabolites from Crescentia cujete as promising antibacterial therapeutics targeting type 2A topoisomerases through molecular dynamics simulation. Comp Biol Med. 2022;145.105432.", "ArticleIdList": ["35344868"]}, {"Citation": "Balogun FO, Naidoo K, Aribisala JO, Pillay C, Sabiu S. Cheminformatics identification and validation of dipeptidyl peptidase-IV modulators from shikimate pathway-derived phenolic acids towards interventive type-2 diabetes therapy. Metabolites. 2022;12:937. doi: 10.3390/metabo12100937.", "ArticleIdList": ["10.3390/metabo12100937", "PMC9608993", "36295839"]}, {"Citation": "Khan S, Bjij I, Betz RM, et al. Reversible versus irreversible inhibition modes of ERK2: a comparative analysis for ERK2 protein kinase in cancer therapy. Future Med Chem. 2018;10(9):1003\u201315. doi: 10.4155/fmc-2017-0275.", "ArticleIdList": ["10.4155/fmc-2017-0275", "29629569"]}, {"Citation": "Zhang D, Lazim R. Application of conventional molecular dynamics simulation in evaluating the stability of apomyoglobin in urea solution. Scientif Rep. 2017;7(44651).", "ArticleIdList": ["PMC5353640", "28300210"]}, {"Citation": "Khan S, Fakhar Z, Hussain A, Ahmad A, Jairajpuri D, Alajmi M, Hassan M. Structure-based identification of potential SARS-CoV-2 main protease inhibitors. J Biomolec Struct Dyn. 2020;1\u201314.", "ArticleIdList": ["PMC7682383", "33210561"]}, {"Citation": "Chen J, Almo SC, Wu Y. General principles of binding between cell surface receptors and multi-specific ligands: a computational study. PLoS Comput Biol. 2017;13(10):e1005805. doi: 10.1371/journal.pcbi.1005805.", "ArticleIdList": ["10.1371/journal.pcbi.1005805", "PMC5654264", "29016600"]}, {"Citation": "Kairys V, Baranauskiene L, Kazlauskiene M, Matulis D, Kazlauskas E. Binding affinity in drug design: experimental and computational techniques. Expert Opin Drug Discov. 2019;14:755\u201368. doi: 10.1080/17460441.2019.1623202.", "ArticleIdList": ["10.1080/17460441.2019.1623202", "31146609"]}, {"Citation": "Vergara R, Romero-Romero S, Vel\u00e1zquez-L\u00f3pez I, et al. The interplay of protein-ligand and water-mediated interactions shape affinity and selectivity in the LAO binding protein. FEBS J. 2020;287(4):763\u201382. doi: 10.1111/febs.15019.", "ArticleIdList": ["10.1111/febs.15019", "31348608"]}, {"Citation": "Izadi H, Stewart KME, Penlidis A. Role of contact electrification and electrostatic interactions in gecko adhesion. J R Soc Interface. 2014;11:371\u201398. doi: 10.1098/rsif.2014.0371.", "ArticleIdList": ["10.1098/rsif.2014.0371", "PMC4233685", "25008078"]}, {"Citation": "Du X, Li Y, Xia YL, Ai SM, Liang J, Sang P, Ji XL, Liu SQ. Insights into protein-ligand interactions: mechanisms, models, and methods. Int J Mol Sci. 2016;17(2):144. doi: 10.3390/ijms17020144.", "ArticleIdList": ["10.3390/ijms17020144", "PMC4783878", "26821017"]}, {"Citation": "Bayas MV, Kearney A, Avramovic A, van der Anton P, Leckband DE. Impact of salt bridges on the equilibrium binding and adhesion of human CD2 and CD58. J Biol Chem. 2007;282(8):5589\u201396. doi: 10.1074/jbc.M607968200.", "ArticleIdList": ["10.1074/jbc.M607968200", "17172599"]}, {"Citation": "Babine RE, Bender SL. Molecular recognition of protein-ligand complexes: applications to drug design. Chem Rev. 1997;97:1359\u2013472. doi: 10.1021/cr960370z.", "ArticleIdList": ["10.1021/cr960370z", "11851455"]}, {"Citation": "Yamashita F, Hashida M. In silico approaches for predicting ADME properties of drugs. Drug Metabol Pharmacokinet. 2004;19:327\u201338. doi: 10.2133/dmpk.19.327.", "ArticleIdList": ["10.2133/dmpk.19.327", "15548844"]}, {"Citation": "Remko M, Boh A, Kov\u00b4a\u02c7cikov\u00b4a L. Molecular structure, pKa, lipophilicity, solubility, absorption, polar surface area, and blood brain barrier penetration of some antiangiogenic agents. Struct Chem. 2011;22:635\u201348. doi: 10.1007/s11224-011-9741-z.", "ArticleIdList": ["10.1007/s11224-011-9741-z"]}, {"Citation": "Price G, Patel DA. Drug Bioavailability 2020.", "ArticleIdList": ["32496732"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "16"}, {"Year": "2023", "Month": "6", "Day": "7"}, {"Year": "2023", "Month": "11", "Day": "16", "Hour": "6", "Minute": "46"}, {"Year": "2023", "Month": "11", "Day": "16", "Hour": "6", "Minute": "45"}, {"Year": "2023", "Month": "11", "Day": "16", "Hour": "4", "Minute": "26"}, {"Year": "2023", "Month": "7", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["37969920", "PMC10638353", "10.1007/s40200-023-01249-7", "1249"]}}], "PubmedBookArticle": []}